|
Jun 27
|
New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V.
|
|
Jun 18
|
Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year?
|
|
Jun 18
|
Acurx Pharmaceuticals, Inc. Announces Exercise of Warrants for $2.67 Million Gross Proceeds
|
|
Jun 17
|
Sector Update: Health Care Stocks Retreat Late Afternoon
|
|
Jun 17
|
Acurx Announces Publication in Lancet Microbe of Phase 2b Clinical Trial Data for Ibezapolstat in CDI
|
|
Jun 9
|
New to The Street's Documentary Specials Break Records: IMG Academy Surpasses 126,000 Views in Just 12 Days
|
|
Jun 9
|
Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Federation of American Societies for Experimental Biology Scientific Conference
|
|
Apr 30
|
Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update
|
|
Apr 28
|
Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
|
|
Mar 14
|
New to The Street & Sight & Sound's Visionaries Series Premieres Tomorrow on Bloomberg at 6:30 PM EST, Featuring Acurx Pharmaceuticals NASDAQ:ACXP
|
|
Mar 10
|
Acurx Pharmaceuticals, Inc. Announces Closing of $1.1 Million Registered Direct Offering
|
|
Mar 3
|
Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics
|
|
Feb 28
|
Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update
|
|
Feb 15
|
New to the Street to Broadcast Show 627 on Bloomberg Television at 6:30 PM EST Today as Sponsored Programming
|
|
Jan 3
|
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
|
|
Sep 26
|
Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 Analogues
|
|
Aug 9
|
New to The Street TV Announces Episode 583, Five Riveting Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Saturday, August 10, 2024, at 6:30 PM ET
|
|
Aug 9
|
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business Update
|
|
May 15
|
Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection
|
|
May 15
|
Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update
|